We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lyophilized Mastermixes and qPCR Kits Assist Pathogen Detection

By LabMedica International staff writers
Posted on 26 Aug 2014
A range of real-time polymerase chain reaction (qPCR) kits is offered for human pathogen detection, food testing, veterinary and agricultural testing, biothreat detection, and more.

The kits are available from Genesig (The Mill Yard; Southampton, UK), which deals with the product range of Primerdesign Ltd. The performance of the reagents and data is good. Customers might even see an improvement in data quality versus many traditional frozen master mixes.

The Oasig freeze drying process stabilizes all of the active components of the kits, allowing these reagents to be shipped and stored at room temperature. They are stable for more than 18 months at ambient temperatures, simplifying the logistics of purchasing, shipping, and using the technology. The complete qPCR kit and reagent packages are supplied quickly and cheaply via standard shipping methods without the need for dry ice or a cold chain of any sort.

The Genesig catalog offers more than 300 qPCR kits for pathogen detection, veterinary testing, meat speciation, and more. If the target of interest is not present it is possible to request a special new kit suitable for the requirements.

Related Links:

Genesig



New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA

Latest Molecular Diagnostics News

Protein Patterns in Blood Can Predict IBD As Early As 16 Years Before Diagnosis

Non-Invasive AI-Powered Urine Test Enables Early Bladder Cancer Detection

New Multi-Biomarker Class Approach Improves Cancer Detection